| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.047 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |